Absorption, half-life, and toxicity of oral aprindine in patients with acute myocardial infarction
- 1 January 1975
- journal article
- Published by Springer Nature in European Journal of Clinical Pharmacology
- Vol. 9 (1) , 21-25
- https://doi.org/10.1007/bf00613425
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Lidocaine in the Prevention of Primary Ventricular FibrillationNew England Journal of Medicine, 1974
- Therapeutic effectivenss and plasma levels of aprindine, a new antidysrhythmic drugEuropean Journal of Clinical Pharmacology, 1974
- Comparative mechanisms of action of antiarrhythmic drugsAmerican Heart Journal, 1974
- Electrophysiologic alterations in cardiac dysrhythmias: Antiarrhythmic effects of aprindineThe American Journal of Cardiology, 1974
- MEXILETINE (KÖ1173) IN THE MANAGEMENT OF VENTRICULAR DYSRHYTHMIASThe Lancet, 1973
- TREATMENT OF VENTRICULAR ARRHYTHMIAS WITH MEXILETINE (K 1173)The Lancet, 1973
- PHARMACOKINETICS OF PROCAINAMIDE IN MAN*Annals of the New York Academy of Sciences, 1971
- LIGNOCAINE GIVEN PROPHYLACTICALLY TO PATIENTS WITH ACUTE MYOCARDIAL INFARCTIONThe Lancet, 1971
- Mechanisms of sudden death and their implications for prevention and managementProgress in Cardiovascular Diseases, 1971
- Antiarrhythmic Prophylaxis with Procainamide in Acute Myocardial InfarctionNew England Journal of Medicine, 1969